n-methylscopolamine has been researched along with 5-((4-(4-(diethylamino)butyl)-1-piperidinyl)acetyl)-10,11-dihydrobenzo(b,e)(1,4)diazepine-11-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernhardt, G; Buschauer, A; Keller, M; Pegoli, A; Read, RW; She, X; Tränkle, C | 1 |
1 other study(ies) available for n-methylscopolamine and 5-((4-(4-(diethylamino)butyl)-1-piperidinyl)acetyl)-10,11-dihydrobenzo(b,e)(1,4)diazepine-11-one
Article | Year |
---|---|
M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
Topics: Allosteric Site; Animals; Benzodiazepinones; Chemistry Techniques, Synthetic; CHO Cells; Cricetulus; Dimerization; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Ligands; N-Methylscopolamine; Piperidines; Radioligand Assay; Receptor, Muscarinic M2; Structure-Activity Relationship | 2015 |